Company Monitoring Page for Dendreon

latest headlines for company on cafepharma

Here's Why Dendreon Isn't Like Other Biotechs
Minyanville
Fri, 08/5/11 - 01:55 pm
Tags:
Dendreon, Provenge, prostate cancer
Dendreon Falls Most Ever After Pulling Sales Forecast on Cancer Therapy
Bloomberg
Thu, 08/4/11 - 04:36 pm
Tags:
Provenge, Dendreon, prostate cancer
Dendreon CEO Dumped $1M in Stock Before Withdrawing Revenue Guidance
BNET Pharma
Thu, 08/4/11 - 01:09 pm
Tags:
Dendreon, Provenge, Pharma CEOs, Mitchell Gold
Dendreon's Blowup Spreads Across Biotech
TheStreet.com
Thu, 08/4/11 - 10:57 am
Tags:
Dendreon, Provenge, InterMune, Human Genome Sciences, Seattle Genetics, Regeneron, Savient
Dendreon: Parsing Provenge's Problems
TheStreet.com
Thu, 08/4/11 - 09:39 am
Tags:
Provenge, Dendreon, vaccines, prostate cancer
Dendreon Earnings Preview: It's All About Provenge Sales
Seeking Alpha
Tue, 08/2/11 - 12:44 pm
Tags:
earnings, Dendreon, Provenge
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Tags:
Alexa, Gilead Sciences, Regeneron, Dendreon, NuPathe, Provenge, Adcetris, Seattle Genetics, Eyelea, Btripla, Zelrix, AZ-004
Revisiting 6 Speculative Biotech Stocks That Hedge Funds Love
Seeking Alpha
Sun, 07/31/11 - 10:18 am
Tags:
Aeterna Zentaris, Cadence Pharmaceuticals, Dendreon, Arena Pharmaceuticals, Sunesis, Aastrom
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
Tags:
M&A, Chelsea Therapeutics, Amgen, Human Genome Sciences, Acorda Therapeutics, Celgene, Dendreon, InterMune, Biomarin, Alnylam, Exelixis
Immunocellular Therapeutics: An Interesting Biotech
Seeking Alpha
Tue, 07/19/11 - 12:12 pm
Tags:
ImmunoCellular Therapeutics, cancer, Bristol-Myers Squibb, Dendreon, Oncothyreon
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Tags:
Human Genome Sciences, Vertex Pharmaceuticals, Acorda Therapeutics, Dendreon, Avanir, lupus, Benlysta, Incivek, hepatitis C, MS, AMPYRA, Provenge, prostate cancer, Nuedexta, PBA
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Sat, 07/16/11 - 11:39 am
Tags:
Exelixis, InterMune, Dendreon, Savient, Acorda Therapeutics
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
Tags:
biotech, Gilead Sciences, Dendreon, PDL Biopharma, Cell Therapeutics, Amgen, Aeterna Zentaris, Xoma, Geron, Orexigen, Zalicus, Spectrum Pharmaceuticals, Ariad Pharmaceuticals, Biogen Idec, Momenta, StemCells
Dendreon News Could Limit Long Term Upside
Seeking Alpha
Sat, 07/9/11 - 10:56 am
Tags:
Dendreon, Provenge, prostate cancer
Ideas in the Biotech Sector
Seeking Alpha
Sat, 07/9/11 - 10:55 am
Tags:
Amag Pharmaceuticals, Dendreon, Oncothyreon
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Tags:
Dendreon, prostate cancer, cancer immunotherapy, Cel-Sci, Cell Therapeutics, ImmunoCellular, Keryx, Teva Pharmaceuticals, Oncothyreon
Dendreon climbs 4% in premarket trading
Marketwatch
Fri, 07/1/11 - 09:58 am
Tags:
Medicare, Dendreon, Provenge, prostate cancer
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
NY Times, NY
Fri, 07/1/11 - 09:55 am
Tags:
Medicare, Provenge, prostate cancer, Dendreon, Roche, Avastin, breast cancer
Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug
Bloomberg
Thu, 06/30/11 - 07:34 pm
Tags:
prostate cancer, Dendreon, Provenge, Medicare
Are Dendreon Executives Properly Incentivized?
Seeking Alpha
Wed, 06/29/11 - 06:55 am
Tags:
Dendreon, executive pay

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.